Endolymphatic exclusion for the treatment of pediatric chylous ascites secondary to neuroblastoma resection: report of two cases
oleh: Andrew Woerner, MD, MS, David S. Shin, MD, Jeffrey Forris Beecham Chick, MD, MPH, FSVM, Caitlin A. Smith, MD, Jay F. Sarthy, MD, PhD, Eric J. Monroe, MD
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2020-07-01 |
Deskripsi
Chylous ascites is a rare, but highly morbid complication of oncologic resection, often associated with retroperitoneal lymphadenectomy. Conservative measures with total parenteral nutrition or lipid-reduced formulas constitute the initial mainstay therapy, but not without risks and failures. This report describes 2 endolymphatic treatment strategies for iatrogenic chylous ascites following neuroblastoma resection. Lymphatic leaks were identified using intranodal lymphangiography, targeted with cone-beam computed tomographic guidance, and embolized with n-butyl cyanoacrylate. There were no adverse outcomes, with complete resolution of chylous ascites and a mean follow-up of 26 months.